Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
16.58
+0.28 (1.72%)
At close: Sep 28, 2026, 4:00 PM EDT
16.69
+0.11 (0.66%)
Pre-market: Sep 29, 2026, 5:24 AM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.01 billion as of September 28, 2026. Its market cap has decreased by -27.39% in one year.
Market Cap
1.01B
Enterprise Value
63.72M
1-Year Change
-27.39%
Ranking
Category
Stock Price
$16.58
ChartMarket Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.01B, an increase of 65.16%. That is a compound annual growth rate of 9.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 1.01B | 22.12% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.07B |
| MeiraGTx Holdings | 1.05B |
| Alto Neuroscience | 1.04B |
| MoonLake Immunotherapeutics | 1.02B |
| Monte Rosa Therapeutics | 1.00B |
| Adlai Nortye Group | 1.00B |
| Odyssey Therapeutics | 982.81M |
| Corvus Pharmaceuticals | 977.49M |